- Home
- AUPH vs XMTR Comparison
AUPH vs XMTR Comparison
Compare AUPH & XMTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- XMTR
- Stock Information
- Founded
- AUPH 1993
- XMTR 2013
- Country
- AUPH Canada
- XMTR United States
- Employees
- AUPH N/A
- XMTR N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- XMTR Industrial Machinery/Components
- Sector
- AUPH Health Care
- XMTR Technology
- Exchange
- AUPH Nasdaq
- XMTR Nasdaq
- Market Cap
- AUPH 1.1B
- XMTR 1.6B
- IPO Year
- AUPH 1999
- XMTR 2021
- Fundamental
- Price
- AUPH $8.63
- XMTR $35.29
- Analyst Decision
- AUPH Strong Buy
- XMTR Buy
- Analyst Count
- AUPH 2
- XMTR 11
- Target Price
- AUPH $11.50
- XMTR $34.82
- AVG Volume (30 Days)
- AUPH 2.1M
- XMTR 594.5K
- Earning Date
- AUPH 07-31-2025
- XMTR 08-07-2025
- Dividend Yield
- AUPH N/A
- XMTR N/A
- EPS Growth
- AUPH N/A
- XMTR N/A
- EPS
- AUPH 0.27
- XMTR N/A
- Revenue
- AUPH $247,295,000.00
- XMTR $573,810,000.00
- Revenue This Year
- AUPH $12.15
- XMTR $21.52
- Revenue Next Year
- AUPH $18.34
- XMTR $17.20
- P/E Ratio
- AUPH $32.66
- XMTR N/A
- Revenue Growth
- AUPH 29.20
- XMTR 19.35
- 52 Week Low
- AUPH $5.20
- XMTR $11.33
- 52 Week High
- AUPH $10.67
- XMTR $45.33
- Technical
- Relative Strength Index (RSI)
- AUPH 54.74
- XMTR 57.33
- Support Level
- AUPH $8.73
- XMTR $32.87
- Resistance Level
- AUPH $9.19
- XMTR $36.76
- Average True Range (ATR)
- AUPH 0.44
- XMTR 1.60
- MACD
- AUPH 0.09
- XMTR 0.06
- Stochastic Oscillator
- AUPH 70.60
- XMTR 71.23
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About XMTR Xometry Inc.
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.